Skip to main content

Navigation group

Type at least 3 characters
1,638 articles

Articles

Perspective

Published on 08 Aug 2022

CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

in Alloimmunity and Transplantation

  • Isabel Martínez-Romera
  • Víctor Galán-Gómez
  • Berta González-Martínez
  • Pilar Guerra García
  • Sonsoles San Román Pacheco
  • Dolores Corral Sánchez
  • Yasmina Mozo del Castillo
  • David Bueno Sánchez
  • Luisa Sisinni
  • Alba González Guerrero
CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation
Frontiers in Immunology
doi 10.3389/fimmu.2022.960412
  • 3,380 views
  • 4 citations